Sartorius (FRA:SRT3) Given a €110.00 Price Target by Berenberg Bank Analysts

Sartorius (FRA:SRT3) has been assigned a €110.00 ($135.80) target price by equities researchers at Berenberg Bank in a research report issued to clients and investors on Monday, March 26th. The firm presently has a “neutral” rating on the stock. Berenberg Bank’s target price would suggest a potential downside of 13.66% from the stock’s current price.

A number of other research analysts have also weighed in on the stock. UBS set a €125.00 ($154.32) target price on shares of Sartorius and gave the stock a “buy” rating in a research report on Friday, February 23rd. Kepler Capital Markets set a €78.00 ($96.30) target price on shares of Sartorius and gave the stock a “neutral” rating in a research report on Wednesday, February 21st. HSBC set a €86.00 ($106.17) target price on shares of Sartorius and gave the stock a “neutral” rating in a research report on Wednesday, February 7th. Nord/LB set a €75.00 ($92.59) target price on shares of Sartorius and gave the stock a “sell” rating in a research report on Friday, February 2nd. Finally, Deutsche Bank set a €90.00 ($111.11) target price on shares of Sartorius and gave the stock a “neutral” rating in a research report on Thursday, February 1st. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. Sartorius currently has a consensus rating of “Hold” and an average price target of €89.27 ($110.21).

How to Become a New Pot Stock Millionaire

Sartorius stock traded down €1.80 ($2.22) on Monday, reaching €127.40 ($157.28). 130,748 shares of the stock were exchanged. Sartorius has a twelve month low of €71.00 ($87.65) and a twelve month high of €124.70 ($153.95).

COPYRIGHT VIOLATION WARNING: This news story was first reported by Macon Daily and is owned by of Macon Daily. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://macondaily.com/2018/04/17/sartorius-srt3-given-a-110-00-price-target-by-berenberg-bank-analysts-updated-updated-updated.html.

About Sartorius

Sartorius Aktiengesellschaft provides pharmaceutical and laboratory equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply